<![CDATA[Debiopharm 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=46332>Thu, 30 Apr 2026 15:38:30 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[Swiss-Based Debiopharm Seeks to Boost Innovation in Japanese Cancer Research Through the New]]>https://www.newswire.co.kr/newsRead.php?no=1023345Tue, 18 Nov 2025 16:06:48 +0900<![CDATA[Debiopharm Recognizes Groundbreaking Japanese Cancer Research During the 83rd Annual Meeting of the Japanese Cancer Association]]>https://www.newswire.co.kr/newsRead.php?no=997248Tue, 24 Sep 2024 09:03:49 +0900<![CDATA[ITM Obtains Exclusive Worldwide License from Debiopharm for CA IX-Targeted Peptide-based Radiopharmaceutical Programs Targeting Solid Tumors]]>https://www.newswire.co.kr/newsRead.php?no=996899Fri, 13 Sep 2024 14:30:00 +0900